D
DySISmedical
Medical device company that manufactures imaging systems that facilitate the non-invasive detection of cancerous lesions.
About DySISmedical
DYSIS Medical specializes in advanced colposcopy solutions, focusing on enhancing cervical disease detection through its patented imaging technology. The company's flagship product, the DYSIS Colposcope, offers clinicians a sophisticated tool for cervical scanning, providing a detailed map of the cervix to aid in the detection of abnormalities. This technology is particularly beneficial for healthcare providers such as OBGYN clinics and women's health centers, aiming to improve patient care standards. Operating in the medical device market, DYSIS Medical generates revenue through the sale and distribution of its colposcopy systems and related accessories. The business model is centered around providing high-quality diagnostic tools that support clinicians in delivering superior care. The DYSIS Colposcope is CE marked and cleared for market, ensuring compliance with regulatory standards. Key clients include healthcare facilities that prioritize advanced diagnostic capabilities to enhance patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2002
- Headquarters
- Natick, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 38.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Non-Invasive medical devices and treatments, Spinout, DT and LS
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | Jul 2018 | $24M | — | Lundbeckfonden Ventures | — |
| EARLY VCEquity / VC | Oct 2014 | $48K | $192K | Undisclosed | — |
Growth signals
Latest recorded traffic for DySISmedical is 1.3K monthly website visits, up 8.3% over the last three months. DySISmedical's team declined 4.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Lundbeckfonden
Series B and later1 investor entered at this stage
Lundbeckfonden Ventures
Other known investors3 additional known investors
Foundation for Research and Technology
AlbionVC
NBGI Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DySISmedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DySISmedical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.